Undervalued Stocks Based On Cash Flows
Results
5
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ROVI | €56.90 | -2.9% | 1.2% | €2.9b | €75.38 | 22.1 | 16.6% | 1.7% | Pharmaceuticals & Biotech | ||
PANG | €1.51 | 0% | -10.7% | €54.2m | n/a | 3.2 | 96.1% | n/a | Pharmaceuticals & Biotech | ||
TUB | €3.42 | 3.5% | -16.2% | €419.7m | €4.17 | 0.6 | 75.5% | 6.0% | Materials | ||
AGIL | €2.20 | -0.9% | -4.3% | €50.5m | €7.00 | 0.6 | 45.2% | n/a | Software | ||
IDR | €51.44 | 9.6% | 39.6% | €9.0b | €66.07 | 20.0 | 14.4% | 0.6% | Software |
Page 1 of 1